• HyperScript First-Strand cDNA Synthesis Kit for EV RNA

  2026-09-03

  Translate scarce, structured RNA from extracellular vesicles into reproducible cDNA for PCR amplification and qPCR reaction design. The HyperScript First-Strand cDNA Synthesis Kit combines thermostable reverse transcription, flexible primer selection, and low-input workflow options for challenging cancer biology samples.

• Estradiol Benzoate: ERα Assay Workflows

  2026-09-03

  Build more reproducible estrogen receptor binding and signaling experiments with Estradiol Benzoate, from solvent-controlled stock preparation to cross-species dose-response design. The workflow also adapts the reference study’s computational-to-experimental logic without overstating unrelated antiviral evidence.

• Topotecan (SKF104864): Mechanism and Research Use

  2026-09-02

  Topotecan (SKF104864) is a semisynthetic camptothecin derivative that inhibits topoisomerase I by stabilizing DNA–enzyme cleavage complexes. Its translational profile spans recurrent ovarian cancer and small cell lung cancer, while preclinical studies use it to model DNA damage, apoptosis induction in glioma cells, and antitumor activity in pediatric solid tumor models.

• HyperScribe Co-transcription mRNA Kit Plus

  2026-09-02

  The HyperScribe Co-transcription mRNA Synthesis Kit Plus is an ARCA capped mRNA synthesis kit that uses T7 RNA Polymerase and supports template-encoded poly(A) tails. The K1406 format is supplied for 25 reactions of 20 μL each and is intended for research workflows such as in vitro translation, RNA vaccine development, and RNA interference experiments.

• RWJ 67657: A Better Way to Read p38 Assays

  2026-09-01

  RWJ 67657, also known as JNJ-3026582, offers selective p38α/β inhibition for cytokine and inflammatory disease research. This article explains how to distinguish direct kinase blockade from inhibitor-induced dephosphorylation when designing and interpreting mechanistic assays.

• Anti Reverse Cap Analog for mRNA Workflows

  2026-09-01

  Anti Reverse Cap Analog, 3´-O-Me-m7G(5')ppp(5')G, helps researchers build consistently capped synthetic mRNA for reporter assays, gene-editing studies, and mechanistic metabolism experiments. Its orientation-controlled design, practical 4:1 cap-to-GTP starting ratio, and reported approximately twofold translation advantage make it a useful optimization lever when RNA output alone does not predict protein output.

• Clathrin-Mediated Entry of Type III GCRV

  2026-08-31

  Wang et al. used inhibitor profiling, transmission electron microscopy, and RT-qPCR to show that genotype III grass carp reovirus GCRV104 enters CIK cells through a dynamin-dependent, acidic clathrin-mediated endocytic pathway. The study also clarifies that nocodazole-sensitive microtubule function is not required under the tested conditions, making the compound a useful mechanistic comparator rather than an antiviral lead in this model.

• miR-18a/ALOXE3 Axis in Glioblastoma

  2026-08-30

  The reference study identifies a miR-18a/ALOXE3 regulatory axis that links lipid metabolism with ferroptosis resistance and glioblastoma cell migration. Its integrated genetic, biochemical, cellular, and orthotopic mouse experiments provide a mechanistic framework for interpreting ALOXE3 as a potential tumor-suppressive factor in GBM rather than merely a correlational marker.

• AL-8810: Prostaglandin F2α Antagonist Workflows

  2026-08-29

  Use AL-8810 to separate PGF2α/FP receptor signaling from downstream vascular, endometrial, and smooth-muscle effects. This workflow combines competitive antagonism, time-resolved pathway assays, and practical controls for reproducible mechanism-of-action studies.

• PGF2α/PTGFR Controls Endometrial Breakdown in Mice

  2026-08-29

  This 2024 study identifies PGF2α signaling through PTGFR, also known as the FP receptor, as a functional driver of endometrial breakdown and vascular remodeling in a mouse menstrual-like model. By combining receptor inhibition with HIF-1α perturbation and promoter-binding analysis, the work connects hypoxia-responsive transcriptional control to prostaglandin-mediated changes in vascular permeability and tissue shedding.

• I-BET-762: From BET Biology to Translational Strategy

  2026-08-28

  I-BET-762 offers translational researchers a selective BET inhibitor framework for connecting LPS-driven inflammatory transcription with BRD4-dependent ferroptosis sensitivity. This article interprets the evidence, defines decision-ready workflows, and outlines how to move from mechanistic signal to robust preclinical strategy.

• V5 Epitope Tag Peptide: From Tag to Kinetic Probe

  2026-08-28

  The V5 Epitope Tag Peptide is examined as more than a detection reagent: it is a sequence-defined control for antibody-based assay design. Learn how antigen presentation, antibody dissociation, and readout selection shape Western blot, immunoprecipitation, localization, and advanced imaging workflows.

• Dabigatran Etexilate: Oral Direct Thrombin Inhibition

  2026-08-27

  The reference review explains why dabigatran etexilate represented a major shift from parenteral anticoagulants and vitamin K antagonists toward oral, predictable direct thrombin inhibition. Its pharmacokinetic independence from CYP450 metabolism, combined with evidence across venous thromboembolism and nonvalvular atrial fibrillation, supports a more targeted approach to anticoagulant selection while keeping renal function and bleeding risk central.

• Viral RIPK3 Degradation Drives Inflammation

  2026-08-27

  Liu and colleagues identified a viral inducer of RIPK3 degradation, or vIRD, that recruits host SCF machinery to ubiquitinate and eliminate the necroptosis adaptor during orthopoxvirus infection. Reverse-genetic and mouse studies showed that vIRD is not simply an intracellular death suppressor: its activity shapes viral replication, inflammation, and disease severity through RIPK3–MLKL-dependent mechanisms.

• O-propargyl-puromycin (OPP) for Protein Synthesis

  2026-08-26

  O-propargyl-puromycin (OPP) converts transient translation into a measurable chemical signal, supporting protein synthesis measurement in cells from bulk cultures to sorted immune populations. This workflow guide applies OPP to the Pcbp1–mitochondrial integrity question in B cells while emphasizing controls, normalization, and troubleshooting.

455 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page